Does Dr. ALEXIS CRUZ-CHACON have financial conflicts of interest?

Dr. ALEXIS CRUZ-CHACON (MD) has received a total of $266,582 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $266,582 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ALEXIS CRUZ-CHACON?

According to CMS Open Payments data, Dr. ALEXIS CRUZ-CHACON received funding from AMGEN ($44,301), JANSSEN PHARMACEUTICALS ($40,119), and GLAXOSMITHKLINE ($36,366).

Does Dr. ALEXIS CRUZ-CHACON receive research grants or speaking fees?

Dr. ALEXIS CRUZ-CHACON has received $266,582 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ALEXIS CRUZ-CHACON

MDReal-Time Hydrated

Specialty: Internal Medicine, Hematology & Oncology

Practice Location: SAN JUAN, PR 00919

NPI Number: 1083898969

LIFETIME INDUSTRY VALUE

$266,582

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. CRUZ-CHACON is a verified Internal Medicine, Hematology & Oncology practitioner based in SAN JUAN, PR.

Between 2021 and 2024, Dr. CRUZ-CHACON had an overall industry promotional and research financial footprint of $266,582 as recorded in the federal CMS Open Payments database.

$266,582 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. CRUZ-CHACON's primary funding source is AMGEN, which accounts for $44,301 (representing 16.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

AMGEN

Rank 1

$44,301

16.6%

JANSSEN PHARMACEUTICALS

Rank 2

$40,119

15%

GLAXOSMITHKLINE

Rank 3

$36,366

13.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.